Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Compass Therapeutics

Clinical trials sponsored by Compass Therapeutics, explained in plain language.

COMPASS Pathways CMPX NASDAQ

COMPASS Therapeutics is a biopharmaceutical company developing psychedelic-based therapies for mental health.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New combo therapy shows promise for Tough-to-Treat bile duct cancer

Disease control Ongoing

This study tests whether adding the experimental drug CTX-009 to standard chemotherapy (paclitaxel) helps adults with advanced bile duct, gallbladder, or ampullary cancer that has worsened after one prior treatment. About 168 participants will be randomly assigned to receive eith…

Phase: PHASE2, PHASE3 • Sponsor: Compass Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 12:30 UTC